The global Breast Cancer Market size was estimated at USD 31.89 Billion in 2022 and is projected to hit around USD 70.51 Billion by 2030 with a registered CAGR of 10.43% during the forecast period 2022 to 2030.

Breast Cancer Market Overview:

Breast cancer is the most common disease in the population. It mostly affects women, and the number of cases is rising. Most of the time, breast cancer starts in the tissues of the breast. Breast cancer symptoms include lumps in the breast, changes in the size and shape of the breast, fluid coming out of the nipple, and itchy, scaly, red patches on the skin. It is a disease that is spread by a disorder that makes the symptoms worse, like pain in the bones, swollen lymph nodes, trouble breathing, and many more.
When genes like Human Epidermal growth factor receptor 2 are present, breast cancer can start to grow (HER2). When this protein is in the body, it makes cancer grow and makes the cells multiply faster. Positive HER2 receptor patients have breast cancer that is more aggressive than other types. There are many treatments that can be used to treat and get rid of the tumour and focus more on HER2. Which makes the market for breast cancer bigger as the number of patients gets bigger every year and the number of people who get better from breast cancer goes up.

Increase research and development with more new technologies and treatments for breast cancer. This is a big reason why the market is growing because the medical field is asking for more new treatments and medicines to help treat patients. Government support with increasing confidence for new developments in medications and better efficiency and effectiveness of treatment and integration of newly developed medications into the medical sector.
Because of how common the coronavirus is, the effect of covid-19 on the breast cancer market led to longer treatment times and more time between treatments. Less people went to the hospital, which led to less breast cancer. The breast cancer market is growing because, after the pandemic, there has been a lot of progress in cancer treatments and medications. Also, the rate of breast cancer is going up every year, and customers and the medical field are asking for more medications.

Market Drivers

The rising number of people with breast cancer is a key market driver. Breast cancer is one of the many diseases that kill people today. It has a big effect on the way of life of many people. This type of cancer needs to be found and treated in the right way. The health care industry is under a lot of pressure to deal with cases of breast cancer. It is a common type of cancer in the US, according to the Cancer Society. Women in the area are hit the hardest by this. Also, the rise of male breast cancer is another thing that is driving this market. In many places, there is a lot of demand for testing, treatment, and services in the breast cancer market.
In this area, it is very important to find these types of cancer early on. In recent years, there has been a lot of interest in imaging for cancer. Because of these things, cancer research and institutes are getting better. A growing number of women with cancer is another thing that drives demand. The number of women with breast cancer is higher than the number of men with breast cancer. Also, the huge amounts of money spent on breast cancer research are another thing that drives demand. All of these factors will make the breast cancer market more profitable as a whole.

Opportunities

As the chemotherapy market grows, there will be a lot of room for growth. People with breast cancer are more likely to get sick. It is a type of cancer that needs to be treated right away to stop it from spreading. In the past few years, chemotherapy and other modified forms of treatment have become more popular. Chemotherapy can stop cancer cells from spreading.
It is a common way to treat most types of cancer. In the next few years, a lot more patients will be getting chemotherapy. More investment in this area will also lead to more changes in the market. During the forecast period, more research is being done on the male breast cancer market. One thing that will help the breast cancer industry grow is the progress of technology in the medical field. As technology and devices for treating cancer get better, good things will happen. Because of these chances to grow, the market will make a lot of money and grow quickly.

Restraints

Patients with cancer can get better care because the breast cancer market is growing faster. Chemotherapy helps a lot of cancer patients get better and live full lives again. But the high price of the treatment is one thing that holds this market back.
There is a big need to control the market and find ways to cut costs. Overall, the cost of chemotherapy is high. Not many people with cancer can pay for this kind of treatment. The breast cancer market may not grow as fast as it could because of the cost and the drop in demand. The high cost of cancer treatments is making more people look for cheaper ways to treat cancer.

Breast Cancer Market Segmentation Analysis

Therapy Insights

Based on therapy, the breast cancer market has more experienced professionals in therapies involved in treatment, more advanced therapies for treating breast cancer, more demand from the market, and more chaos in the population. More research and technology are being put into breast cancer drugs, and the number of treatments is growing, which helps to grow the market rate share.
Targeted therapy for breast cancer is the biggest market, and more people are using it because it works better and has a higher output. New launches of medications are also helping to speed up the breast cancer market. There are drugs like Kadcyla, Afinitor, Lynparza, and Zortress that are used in targeted therapy. With new regulatory approvals, immunotherapy is also getting a bigger share of the breast market.

By Type Insights

Based on an analysis of the types of cancer, the breast cancer market is expected to grow with the largest rate in the hormone receptor during the forecast period. This is because the number of breast cancer cases is rising every year, and new technologies are being developed to treat the disease. The market share of hormone receptor HER2 went down, but new treatments for breast cancer may help the market grow during the forecast period with a higher CAGR rate.

By Distribution Channels

Based on how they got their products to customers, the hospitals with the biggest market share built their own pharmacies inside the hospitals. Because the patients are becoming more dependent on the drugs they need for chemotherapy. During the forecast period, the breast cancer market is expected to grow because patients are asking for more medications and hospital pharmacies are getting better at stocking them.
Due to more software development in hospitals and more online prescriptions in hospitals, online pharmacies have the largest market share. This boosts the breast cancer market, and more online pharmacies and better connections will help the market grow over the next few years.

Regional Insights:

During the Forecast period, North America and Europe are anticipated to be the largest market by region.

Based on where it is, North America has the most market share in breast cancer and is the leader in the market. The market is growing because there are more ways to treat breast cancer and more people are getting it. This is helped by the fact that the government is putting more effort into making new drugs, and the medications are working better and giving better results, which also helps the market grow. There are more people in the market, and they are investing more in new products and growing the size of the market. With a growing number of patients and needs, Asia Pacific will have the second largest market share. The market is growing in Europe, Latin America, the Middle East, and Africa.

Scope Analysis

Recent Development

• In September 2020, breast cancer market company Natco Pharma received FDA approval to begin collaborating on Lapatinib Tablets, a product from marketing partner Lupin. NATCO was the first applicant for Lapatinib Tablets. The same verified certificate was provided.
• In June 2020, Phesgo also received US federal approval to treat skin and related problems. Depending on the diagnostic test, patients are selected for this test.

The Global Breast Cancer Market has been segmented into:

By Therapy

• Targeted Therapy
  • Abemaciclib
  • Adotrastuzumab Emtansine
  • Everolimus
  • Trastuzumab
  • Ribociclib
  • Palbocicib
  • Pertuzumab
  • Olaparib
  • Others
• Hormonal Therapy
  • Selective Estrogen Receptor Modulators
  • Aromatase Inhibitors
  • Estrogen Receptor Downregulators
  • Chemotherapy ( Epothiones, Taxanes, Alkylating agents, Anthracyclines, Anti-metabolites)
  • Immunotherapy
• Surgery and radiation therapy
• Biologic therapy

By Cancer Type

• Hormone Receptor
• HER2+

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

By Companies

• Merck & Co
• Bristol Myers Squiib
• Kyowa Kirin
• Eisai Co.Ltd
• Sanofi
• Pfizer Inc
• AstraZeneca
• Novartis AG
• Eli Lilly and Company
• Genentech
• Mylan Laboratories
• Celltrion
• Fresenius Kabi
• Baxter Healthcare Corporation
• Halozyme Inc
• GlaxoSmithKline

Overview of the regional outlook of the Breast Cancer Market:

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic and non-economic factors;
• Provision of market value (USD Billion) data for each segment and sub-segment;
• Indicates the region and segment that is expected to witness the fastest growth and to dominate the market;
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the market's dominance by region;
• Analysis by product/service type
• Competitive landscape that includes the market ranking of the top competitors, as well as new service/product launches, collaborations, business expansions, and acquisitions of companies featured during the previous five years
• Extensive company profiles with business overview, company insights, product benchmarking, and SWOT analysis for the leading market players
• The current and future market outlook of the industry in light of recent developments (which include growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions)
• Includes an in-depth analysis of the market from multiple perspectives using Porter's five forces analysis Provides market insight across the Value Chain
• Market dynamics situation, as well as development potential for the market in the coming years
• 6-month post-sale analyst assistance

Frequently Asked Questions-

What is the CAGR of Breast Cancer Market?

The Breast Cancer Market is growing at a CAGR of 10.43% During Forecast Period.

What is the key offering of Breast Cancer Market?

Targeted Therapy, Hormonal Therapy, Surgery and radiation therapy, Biologic therapy

What are the key applications of Breast Cancer Market?

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

Who are the key players in Breast Cancer Market?

Merck & Co, Bristol Myers Squiib, Kyowa Kirin, Eisai Co.Ltd, Sanofi, Pfizer Inc, AstraZeneca, Novartis AG, Eli Lilly and Company, Genentech, Mylan Laboratories, Celltrion, Fresenius Kabi, Baxter Healthcare Corporation, Halozyme Inc, GlaxoSmithKline